TAMPA, Fla., June 30, 2025--industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) ...

industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) Market Map Report, developed ...

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain ...

With 80% of clinical trial data coming from unstructured sources, LUCCID solves the critical bottleneck tied to the manual extraction and transformation of unstructured data for trials.

Axtria Inc., an AI-first data analytics innovator transforming life sciences, today announced the launch of LUCCID, short for LLM-based Unstructured Clinical Concept Identification. This ...

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a ...

The clinical trial demonstrated significant improvement of hepatic, muscle and adipose tissue insulin resistance in patients with MASLD and T2D treated with lanifibranor. The proof-of-concept trial ...

Concept Medical is the developer of the MagicTouch family of Sirolimus Coated Balloons (SCBs)-the world's first and most utilized SCB technology-well recognized for its versatility and efficacy in ...